Connection

Hong Shan to Cell Line, Tumor

Back to Details
This is a "connection" page, showing publications Hong Shan has written about Cell Line, Tumor.
Hong Shan
Connection Strength
0.224
Cell Line, Tumor
  1. ZnAs@SiO2 nanoparticles as a potential anti-tumor drug for targeting stemness and epithelial-mesenchymal transition in hepatocellular carcinoma via SHP-1/JAK2/STAT3 signaling. Theranostics. 2019; 9(15):4391-4408.
    View in: PubMed
    Score: 0.103
  2. Versatile Octapod-Shaped Hollow Porous Manganese(II) Oxide Nanoplatform for Real-Time Visualization of Cargo Delivery. Nano Lett. 2019 08 14; 19(8):5394-5402.
    View in: PubMed
    Score: 0.026
  3. Targeted arsenite-loaded magnetic multifunctional nanoparticles for treatment of hepatocellular carcinoma. Nanotechnology. 2019 Apr 26; 30(17):175101.
    View in: PubMed
    Score: 0.025
  4. Facile synthesis of aquo-cisplatin arsenite multidrug nanocomposites for overcoming drug resistance and efficient combination therapy. Biomater Sci. 2018 Dec 18; 7(1):262-271.
    View in: PubMed
    Score: 0.025
  5. Characterizing viscoelastic properties of breast cancer tissue in a mouse model using indentation. J Biomech. 2018 03 01; 69:81-89.
    View in: PubMed
    Score: 0.023
  6. MiR-199a-5p suppresses tumorigenesis by targeting clathrin heavy chain in hepatocellular carcinoma. Cell Biochem Funct. 2017 Mar; 35(2):98-104.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.